Haematologica (Feb 2024)
Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study
- Fredrik H. Schjesvold,
- Heinz Ludwig,
- Sossana Delimpasi,
- Pawel Robak,
- Daniel Coriu,
- Waldemar Tomczak,
- Ludek Pour,
- Ivan Spicka,
- Meletios-Athanasios Dimopoulos,
- Tamas Masszi,
- Natalia G. Chernova,
- Anna Sandberg,
- Marcus Thuresson,
- Stefan Norin,
- Nicolaas A. Bakker,
- Maria-Victoria Mateos,
- Paul G. Richardson,
- Pieter Sonneveld
Affiliations
- Fredrik H. Schjesvold
- Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
- Heinz Ludwig
- Department of Medicine I, Center for Medical Oncology and Hematology with Outpatient Department and Palliative Care, Wilhelminen Cancer Research Institute, Vienna
- Sossana Delimpasi
- Bone Marrow Transplantation Unit and Department of Hematology, Evangelismos Hospital, Athens, Greece
- Pawel Robak
- Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic
- Daniel Coriu
- University of Medicine and Pharmacy "Carol Davila", Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
- Waldemar Tomczak
- Department of Hemato-Oncology and Bone Marrow Transplantation, Medical University of Lublin
- Ludek Pour
- Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Babak Myeloma Group, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- Ivan Spicka
- 1st Department of Medicine - Department of Hematology, First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic
- Meletios-Athanasios Dimopoulos
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
- Tamas Masszi
- Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary
- Natalia G. Chernova
- National Research Center for Haematology, Moscow, Russia
- Anna Sandberg
- Oncopeptides AB, Stockholm, Sweden
- Marcus Thuresson
- Oncopeptides AB, Stockholm, Sweden
- Stefan Norin
- Oncopeptides AB, Stockholm, Sweden
- Nicolaas A. Bakker
- Oncopeptides AB, Stockholm, Sweden
- Maria-Victoria Mateos
- Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain
- Paul G. Richardson
- Dana-Farber Cancer Institute, Boston, MA
- Pieter Sonneveld
- Erasmus MC Cancer Institute, Rotterdam
- DOI
- https://doi.org/10.3324/haematol.2023.284635
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
